The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z, Ni W, Li JL, Lin S, Zhou X, Sun Y, Li JW, Leon ME, Hurtado MD, Zolotukhin S, Liu C, Lu J, Griffin JD, Kaye FJ, Wu L.
Chen Z, et al. Among authors: li jw, li jl.
JCI Insight. 2021 Apr 8;6(7):e139497. doi: 10.1172/jci.insight.139497.
JCI Insight. 2021.
PMID: 33830080
Free PMC article.